nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—PPARG—liver cancer	0.455	1	CbGaD
Telmisartan—ABCC2—Sorafenib—liver cancer	0.0776	0.251	CbGbCtD
Telmisartan—ABCG2—Sorafenib—liver cancer	0.0702	0.227	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—liver cancer	0.0471	0.152	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—liver cancer	0.0426	0.138	CbGbCtD
Telmisartan—ABCC2—bile canaliculus—liver cancer	0.0352	0.566	CbGeAlD
Telmisartan—CYP2C19—Sorafenib—liver cancer	0.0314	0.101	CbGbCtD
Telmisartan—ABCB1—Sorafenib—liver cancer	0.0253	0.0818	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—liver cancer	0.0154	0.0496	CbGbCtD
Telmisartan—ABCC2—bile duct—liver cancer	0.011	0.177	CbGeAlD
Telmisartan—ABCC2—bile—liver cancer	0.00845	0.136	CbGeAlD
Telmisartan—PPARG—embryo—liver cancer	0.00169	0.0272	CbGeAlD
Telmisartan—SLCO1B3—liver—liver cancer	0.00157	0.0252	CbGeAlD
Telmisartan—AGTR1—liver—liver cancer	0.000952	0.0153	CbGeAlD
Telmisartan—PPARG—liver—liver cancer	0.000783	0.0126	CbGeAlD
Telmisartan—ABCC2—liver—liver cancer	0.000688	0.0111	CbGeAlD
Telmisartan—CYP2C19—liver—liver cancer	0.000591	0.0095	CbGeAlD
Telmisartan—ABCB1—embryo—liver cancer	0.000535	0.0086	CbGeAlD
Telmisartan—ABCG2—liver—liver cancer	0.000502	0.00806	CbGeAlD
Telmisartan—Cardiac failure congestive—Epirubicin—liver cancer	0.000275	0.00279	CcSEcCtD
Telmisartan—Gastrointestinal pain—Sorafenib—liver cancer	0.000271	0.00275	CcSEcCtD
Telmisartan—Renal failure acute—Epirubicin—liver cancer	0.00027	0.00274	CcSEcCtD
Telmisartan—Increased appetite—Epirubicin—liver cancer	0.000265	0.00269	CcSEcCtD
Telmisartan—Diabetes mellitus—Doxorubicin—liver cancer	0.000265	0.00269	CcSEcCtD
Telmisartan—Hepatic function abnormal—Doxorubicin—liver cancer	0.000264	0.00268	CcSEcCtD
Telmisartan—Urticaria—Sorafenib—liver cancer	0.000263	0.00267	CcSEcCtD
Telmisartan—Abdominal pain—Sorafenib—liver cancer	0.000262	0.00266	CcSEcCtD
Telmisartan—Body temperature increased—Sorafenib—liver cancer	0.000262	0.00266	CcSEcCtD
Telmisartan—Renal impairment—Epirubicin—liver cancer	0.000262	0.00266	CcSEcCtD
Telmisartan—Purpura—Epirubicin—liver cancer	0.000259	0.00263	CcSEcCtD
Telmisartan—Vascular purpura—Doxorubicin—liver cancer	0.000258	0.00262	CcSEcCtD
Telmisartan—Eczema—Doxorubicin—liver cancer	0.000257	0.00261	CcSEcCtD
Telmisartan—Hypoglycaemia—Epirubicin—liver cancer	0.000255	0.00259	CcSEcCtD
Telmisartan—Cardiac failure congestive—Doxorubicin—liver cancer	0.000254	0.00258	CcSEcCtD
Telmisartan—Renal failure acute—Doxorubicin—liver cancer	0.00025	0.00254	CcSEcCtD
Telmisartan—Pain in extremity—Epirubicin—liver cancer	0.000249	0.00253	CcSEcCtD
Telmisartan—Osteoarthritis—Epirubicin—liver cancer	0.000249	0.00253	CcSEcCtD
Telmisartan—ABCB1—liver—liver cancer	0.000247	0.00398	CbGeAlD
Telmisartan—Increased appetite—Doxorubicin—liver cancer	0.000246	0.00249	CcSEcCtD
Telmisartan—Migraine—Epirubicin—liver cancer	0.000245	0.00249	CcSEcCtD
Telmisartan—Hypersensitivity—Sorafenib—liver cancer	0.000244	0.00248	CcSEcCtD
Telmisartan—Renal impairment—Doxorubicin—liver cancer	0.000242	0.00246	CcSEcCtD
Telmisartan—Face oedema—Epirubicin—liver cancer	0.000241	0.00244	CcSEcCtD
Telmisartan—Purpura—Doxorubicin—liver cancer	0.000239	0.00243	CcSEcCtD
Telmisartan—Asthenia—Sorafenib—liver cancer	0.000238	0.00241	CcSEcCtD
Telmisartan—Hypoglycaemia—Doxorubicin—liver cancer	0.000236	0.0024	CcSEcCtD
Telmisartan—Pruritus—Sorafenib—liver cancer	0.000235	0.00238	CcSEcCtD
Telmisartan—Blood creatinine increased—Epirubicin—liver cancer	0.000234	0.00237	CcSEcCtD
Telmisartan—Osteoarthritis—Doxorubicin—liver cancer	0.000231	0.00234	CcSEcCtD
Telmisartan—Pain in extremity—Doxorubicin—liver cancer	0.000231	0.00234	CcSEcCtD
Telmisartan—Dry skin—Epirubicin—liver cancer	0.000229	0.00232	CcSEcCtD
Telmisartan—Orthostatic hypotension—Epirubicin—liver cancer	0.000228	0.00231	CcSEcCtD
Telmisartan—Migraine—Doxorubicin—liver cancer	0.000227	0.0023	CcSEcCtD
Telmisartan—Hypokalaemia—Epirubicin—liver cancer	0.000227	0.0023	CcSEcCtD
Telmisartan—Diarrhoea—Sorafenib—liver cancer	0.000227	0.0023	CcSEcCtD
Telmisartan—Breast disorder—Epirubicin—liver cancer	0.000225	0.00229	CcSEcCtD
Telmisartan—Face oedema—Doxorubicin—liver cancer	0.000223	0.00226	CcSEcCtD
Telmisartan—Gastritis—Epirubicin—liver cancer	0.000221	0.00224	CcSEcCtD
Telmisartan—Muscular weakness—Epirubicin—liver cancer	0.00022	0.00223	CcSEcCtD
Telmisartan—Dizziness—Sorafenib—liver cancer	0.000219	0.00223	CcSEcCtD
Telmisartan—Abdominal distension—Epirubicin—liver cancer	0.000217	0.0022	CcSEcCtD
Telmisartan—Blood creatinine increased—Doxorubicin—liver cancer	0.000216	0.00219	CcSEcCtD
Telmisartan—Asthma—Epirubicin—liver cancer	0.000215	0.00219	CcSEcCtD
Telmisartan—Eosinophilia—Epirubicin—liver cancer	0.000213	0.00217	CcSEcCtD
Telmisartan—Dry skin—Doxorubicin—liver cancer	0.000211	0.00215	CcSEcCtD
Telmisartan—Vomiting—Sorafenib—liver cancer	0.000211	0.00214	CcSEcCtD
Telmisartan—Orthostatic hypotension—Doxorubicin—liver cancer	0.000211	0.00214	CcSEcCtD
Telmisartan—Hypokalaemia—Doxorubicin—liver cancer	0.00021	0.00213	CcSEcCtD
Telmisartan—Angina pectoris—Epirubicin—liver cancer	0.00021	0.00213	CcSEcCtD
Telmisartan—Rash—Sorafenib—liver cancer	0.000209	0.00212	CcSEcCtD
Telmisartan—Dermatitis—Sorafenib—liver cancer	0.000209	0.00212	CcSEcCtD
Telmisartan—Breast disorder—Doxorubicin—liver cancer	0.000208	0.00212	CcSEcCtD
Telmisartan—Headache—Sorafenib—liver cancer	0.000208	0.00211	CcSEcCtD
Telmisartan—Bronchitis—Epirubicin—liver cancer	0.000207	0.0021	CcSEcCtD
Telmisartan—Gastritis—Doxorubicin—liver cancer	0.000204	0.00207	CcSEcCtD
Telmisartan—Muscular weakness—Doxorubicin—liver cancer	0.000203	0.00207	CcSEcCtD
Telmisartan—Dysuria—Epirubicin—liver cancer	0.000201	0.00205	CcSEcCtD
Telmisartan—Abdominal distension—Doxorubicin—liver cancer	0.000201	0.00204	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Epirubicin—liver cancer	0.0002	0.00203	CcSEcCtD
Telmisartan—Asthma—Doxorubicin—liver cancer	0.000199	0.00202	CcSEcCtD
Telmisartan—Pollakiuria—Epirubicin—liver cancer	0.000199	0.00202	CcSEcCtD
Telmisartan—Eosinophilia—Doxorubicin—liver cancer	0.000197	0.002	CcSEcCtD
Telmisartan—Nausea—Sorafenib—liver cancer	0.000197	0.002	CcSEcCtD
Telmisartan—Angina pectoris—Doxorubicin—liver cancer	0.000194	0.00197	CcSEcCtD
Telmisartan—Pneumonia—Epirubicin—liver cancer	0.000193	0.00196	CcSEcCtD
Telmisartan—Infestation NOS—Epirubicin—liver cancer	0.000192	0.00195	CcSEcCtD
Telmisartan—Infestation—Epirubicin—liver cancer	0.000192	0.00195	CcSEcCtD
Telmisartan—Bronchitis—Doxorubicin—liver cancer	0.000192	0.00195	CcSEcCtD
Telmisartan—Renal failure—Epirubicin—liver cancer	0.000189	0.00192	CcSEcCtD
Telmisartan—Neuropathy peripheral—Epirubicin—liver cancer	0.000188	0.00191	CcSEcCtD
Telmisartan—Conjunctivitis—Epirubicin—liver cancer	0.000187	0.0019	CcSEcCtD
Telmisartan—Urinary tract infection—Epirubicin—liver cancer	0.000187	0.0019	CcSEcCtD
Telmisartan—Dysuria—Doxorubicin—liver cancer	0.000186	0.00189	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000185	0.00188	CcSEcCtD
Telmisartan—Pollakiuria—Doxorubicin—liver cancer	0.000184	0.00187	CcSEcCtD
Telmisartan—Haematuria—Epirubicin—liver cancer	0.000183	0.00186	CcSEcCtD
Telmisartan—Hepatobiliary disease—Epirubicin—liver cancer	0.000182	0.00184	CcSEcCtD
Telmisartan—Epistaxis—Epirubicin—liver cancer	0.000181	0.00184	CcSEcCtD
Telmisartan—Sinusitis—Epirubicin—liver cancer	0.00018	0.00183	CcSEcCtD
Telmisartan—Pneumonia—Doxorubicin—liver cancer	0.000179	0.00181	CcSEcCtD
Telmisartan—Infestation—Doxorubicin—liver cancer	0.000178	0.0018	CcSEcCtD
Telmisartan—Infestation NOS—Doxorubicin—liver cancer	0.000178	0.0018	CcSEcCtD
Telmisartan—Bradycardia—Epirubicin—liver cancer	0.000176	0.00178	CcSEcCtD
Telmisartan—Renal failure—Doxorubicin—liver cancer	0.000175	0.00177	CcSEcCtD
Telmisartan—Neuropathy peripheral—Doxorubicin—liver cancer	0.000174	0.00177	CcSEcCtD
Telmisartan—Rhinitis—Epirubicin—liver cancer	0.000173	0.00176	CcSEcCtD
Telmisartan—Urinary tract infection—Doxorubicin—liver cancer	0.000173	0.00175	CcSEcCtD
Telmisartan—Conjunctivitis—Doxorubicin—liver cancer	0.000173	0.00175	CcSEcCtD
Telmisartan—Hypoaesthesia—Epirubicin—liver cancer	0.000172	0.00174	CcSEcCtD
Telmisartan—Pharyngitis—Epirubicin—liver cancer	0.000171	0.00174	CcSEcCtD
Telmisartan—Urinary tract disorder—Epirubicin—liver cancer	0.00017	0.00173	CcSEcCtD
Telmisartan—Oedema peripheral—Epirubicin—liver cancer	0.00017	0.00172	CcSEcCtD
Telmisartan—Haematuria—Doxorubicin—liver cancer	0.000169	0.00172	CcSEcCtD
Telmisartan—Connective tissue disorder—Epirubicin—liver cancer	0.000169	0.00172	CcSEcCtD
Telmisartan—Urethral disorder—Epirubicin—liver cancer	0.000169	0.00172	CcSEcCtD
Telmisartan—Hepatobiliary disease—Doxorubicin—liver cancer	0.000168	0.00171	CcSEcCtD
Telmisartan—Epistaxis—Doxorubicin—liver cancer	0.000168	0.0017	CcSEcCtD
Telmisartan—Sinusitis—Doxorubicin—liver cancer	0.000167	0.00169	CcSEcCtD
Telmisartan—Visual impairment—Epirubicin—liver cancer	0.000166	0.00169	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—liver cancer	0.000162	0.00165	CcSEcCtD
Telmisartan—Eye disorder—Epirubicin—liver cancer	0.000161	0.00164	CcSEcCtD
Telmisartan—Tinnitus—Epirubicin—liver cancer	0.000161	0.00163	CcSEcCtD
Telmisartan—Flushing—Epirubicin—liver cancer	0.00016	0.00162	CcSEcCtD
Telmisartan—Cardiac disorder—Epirubicin—liver cancer	0.00016	0.00162	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—liver cancer	0.00016	0.00162	CcSEcCtD
Telmisartan—Hypoaesthesia—Doxorubicin—liver cancer	0.000159	0.00161	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—liver cancer	0.000158	0.00161	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—liver cancer	0.000158	0.0016	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—liver cancer	0.000157	0.0016	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—liver cancer	0.000157	0.00159	CcSEcCtD
Telmisartan—Angiopathy—Epirubicin—liver cancer	0.000156	0.00159	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—liver cancer	0.000156	0.00159	CcSEcCtD
Telmisartan—Immune system disorder—Epirubicin—liver cancer	0.000156	0.00158	CcSEcCtD
Telmisartan—Mediastinal disorder—Epirubicin—liver cancer	0.000155	0.00158	CcSEcCtD
Telmisartan—Chills—Epirubicin—liver cancer	0.000155	0.00157	CcSEcCtD
Telmisartan—Arrhythmia—Epirubicin—liver cancer	0.000154	0.00156	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—liver cancer	0.000154	0.00156	CcSEcCtD
Telmisartan—Mental disorder—Epirubicin—liver cancer	0.000151	0.00153	CcSEcCtD
Telmisartan—Erythema—Epirubicin—liver cancer	0.00015	0.00152	CcSEcCtD
Telmisartan—Malnutrition—Epirubicin—liver cancer	0.00015	0.00152	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—liver cancer	0.000149	0.00151	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—liver cancer	0.000149	0.00151	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—liver cancer	0.000148	0.0015	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—liver cancer	0.000148	0.0015	CcSEcCtD
Telmisartan—Flatulence—Epirubicin—liver cancer	0.000148	0.0015	CcSEcCtD
Telmisartan—Tension—Epirubicin—liver cancer	0.000147	0.0015	CcSEcCtD
Telmisartan—Dysgeusia—Epirubicin—liver cancer	0.000147	0.00149	CcSEcCtD
Telmisartan—Nervousness—Epirubicin—liver cancer	0.000146	0.00148	CcSEcCtD
Telmisartan—Back pain—Epirubicin—liver cancer	0.000145	0.00147	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—liver cancer	0.000145	0.00147	CcSEcCtD
Telmisartan—Muscle spasms—Epirubicin—liver cancer	0.000144	0.00147	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—liver cancer	0.000144	0.00146	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—liver cancer	0.000144	0.00146	CcSEcCtD
Telmisartan—Chills—Doxorubicin—liver cancer	0.000143	0.00145	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—liver cancer	0.000143	0.00145	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—liver cancer	0.00014	0.00142	CcSEcCtD
Telmisartan—Ill-defined disorder—Epirubicin—liver cancer	0.000139	0.00141	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—liver cancer	0.000139	0.00141	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—liver cancer	0.000139	0.00141	CcSEcCtD
Telmisartan—Anaemia—Epirubicin—liver cancer	0.000139	0.00141	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—liver cancer	0.000137	0.00139	CcSEcCtD
Telmisartan—Tension—Doxorubicin—liver cancer	0.000136	0.00138	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—liver cancer	0.000136	0.00138	CcSEcCtD
Telmisartan—Malaise—Epirubicin—liver cancer	0.000135	0.00137	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—liver cancer	0.000135	0.00137	CcSEcCtD
Telmisartan—Vertigo—Epirubicin—liver cancer	0.000135	0.00137	CcSEcCtD
Telmisartan—Syncope—Epirubicin—liver cancer	0.000135	0.00137	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—liver cancer	0.000134	0.00136	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—liver cancer	0.000134	0.00136	CcSEcCtD
Telmisartan—Palpitations—Epirubicin—liver cancer	0.000133	0.00135	CcSEcCtD
Telmisartan—Loss of consciousness—Epirubicin—liver cancer	0.000132	0.00134	CcSEcCtD
Telmisartan—Cough—Epirubicin—liver cancer	0.000131	0.00133	CcSEcCtD
Telmisartan—Hypertension—Epirubicin—liver cancer	0.00013	0.00132	CcSEcCtD
Telmisartan—Ill-defined disorder—Doxorubicin—liver cancer	0.000129	0.00131	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—liver cancer	0.000128	0.0013	CcSEcCtD
Telmisartan—Arthralgia—Epirubicin—liver cancer	0.000128	0.0013	CcSEcCtD
Telmisartan—Chest pain—Epirubicin—liver cancer	0.000128	0.0013	CcSEcCtD
Telmisartan—Myalgia—Epirubicin—liver cancer	0.000128	0.0013	CcSEcCtD
Telmisartan—Anxiety—Epirubicin—liver cancer	0.000127	0.00129	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000127	0.00129	CcSEcCtD
Telmisartan—Discomfort—Epirubicin—liver cancer	0.000126	0.00128	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—liver cancer	0.000125	0.00127	CcSEcCtD
Telmisartan—Dry mouth—Epirubicin—liver cancer	0.000125	0.00127	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—liver cancer	0.000125	0.00127	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—liver cancer	0.000125	0.00126	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—liver cancer	0.000123	0.00125	CcSEcCtD
Telmisartan—Oedema—Epirubicin—liver cancer	0.000123	0.00124	CcSEcCtD
Telmisartan—Anaphylactic shock—Epirubicin—liver cancer	0.000123	0.00124	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—liver cancer	0.000122	0.00124	CcSEcCtD
Telmisartan—Infection—Epirubicin—liver cancer	0.000122	0.00124	CcSEcCtD
Telmisartan—Cough—Doxorubicin—liver cancer	0.000121	0.00123	CcSEcCtD
Telmisartan—Shock—Epirubicin—liver cancer	0.000121	0.00122	CcSEcCtD
Telmisartan—Nervous system disorder—Epirubicin—liver cancer	0.00012	0.00122	CcSEcCtD
Telmisartan—Thrombocytopenia—Epirubicin—liver cancer	0.00012	0.00122	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—liver cancer	0.00012	0.00122	CcSEcCtD
Telmisartan—Tachycardia—Epirubicin—liver cancer	0.00012	0.00121	CcSEcCtD
Telmisartan—Skin disorder—Epirubicin—liver cancer	0.000119	0.00121	CcSEcCtD
Telmisartan—Hyperhidrosis—Epirubicin—liver cancer	0.000118	0.0012	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—liver cancer	0.000118	0.0012	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—liver cancer	0.000118	0.0012	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—liver cancer	0.000118	0.0012	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—liver cancer	0.000118	0.0012	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000117	0.00119	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—liver cancer	0.000117	0.00119	CcSEcCtD
Telmisartan—Anorexia—Epirubicin—liver cancer	0.000117	0.00119	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—liver cancer	0.000116	0.00117	CcSEcCtD
Telmisartan—Hypotension—Epirubicin—liver cancer	0.000114	0.00116	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—liver cancer	0.000113	0.00115	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—liver cancer	0.000113	0.00115	CcSEcCtD
Telmisartan—Infection—Doxorubicin—liver cancer	0.000113	0.00114	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000112	0.00113	CcSEcCtD
Telmisartan—Shock—Doxorubicin—liver cancer	0.000112	0.00113	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—liver cancer	0.000111	0.00113	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—liver cancer	0.000111	0.00113	CcSEcCtD
Telmisartan—Insomnia—Epirubicin—liver cancer	0.000111	0.00112	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—liver cancer	0.000111	0.00112	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—liver cancer	0.00011	0.00112	CcSEcCtD
Telmisartan—Paraesthesia—Epirubicin—liver cancer	0.00011	0.00112	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—liver cancer	0.00011	0.00111	CcSEcCtD
Telmisartan—Dyspnoea—Epirubicin—liver cancer	0.000109	0.00111	CcSEcCtD
Telmisartan—Somnolence—Epirubicin—liver cancer	0.000109	0.00111	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—liver cancer	0.000108	0.0011	CcSEcCtD
Telmisartan—Dyspepsia—Epirubicin—liver cancer	0.000108	0.00109	CcSEcCtD
Telmisartan—Decreased appetite—Epirubicin—liver cancer	0.000107	0.00108	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—liver cancer	0.000106	0.00108	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Epirubicin—liver cancer	0.000106	0.00107	CcSEcCtD
Telmisartan—Fatigue—Epirubicin—liver cancer	0.000106	0.00107	CcSEcCtD
Telmisartan—Pain—Epirubicin—liver cancer	0.000105	0.00106	CcSEcCtD
Telmisartan—Constipation—Epirubicin—liver cancer	0.000105	0.00106	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000103	0.00105	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—liver cancer	0.000103	0.00104	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—liver cancer	0.000102	0.00103	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—liver cancer	0.000101	0.00103	CcSEcCtD
Telmisartan—Feeling abnormal—Epirubicin—liver cancer	0.000101	0.00102	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—liver cancer	0.000101	0.00102	CcSEcCtD
Telmisartan—Gastrointestinal pain—Epirubicin—liver cancer	0.0001	0.00102	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—liver cancer	9.98e-05	0.00101	CcSEcCtD
Telmisartan—Decreased appetite—Doxorubicin—liver cancer	9.86e-05	0.001	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—liver cancer	9.79e-05	0.000994	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—liver cancer	9.77e-05	0.000992	CcSEcCtD
Telmisartan—Urticaria—Epirubicin—liver cancer	9.73e-05	0.000988	CcSEcCtD
Telmisartan—Pain—Doxorubicin—liver cancer	9.7e-05	0.000984	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—liver cancer	9.7e-05	0.000984	CcSEcCtD
Telmisartan—Body temperature increased—Epirubicin—liver cancer	9.69e-05	0.000983	CcSEcCtD
Telmisartan—Abdominal pain—Epirubicin—liver cancer	9.69e-05	0.000983	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—liver cancer	9.34e-05	0.000948	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—liver cancer	9.27e-05	0.000941	CcSEcCtD
Telmisartan—Hypersensitivity—Epirubicin—liver cancer	9.03e-05	0.000916	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—liver cancer	9.01e-05	0.000914	CcSEcCtD
Telmisartan—Abdominal pain—Doxorubicin—liver cancer	8.96e-05	0.00091	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—liver cancer	8.96e-05	0.00091	CcSEcCtD
Telmisartan—Asthenia—Epirubicin—liver cancer	8.79e-05	0.000892	CcSEcCtD
Telmisartan—Pruritus—Epirubicin—liver cancer	8.67e-05	0.00088	CcSEcCtD
Telmisartan—Diarrhoea—Epirubicin—liver cancer	8.38e-05	0.000851	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—liver cancer	8.35e-05	0.000848	CcSEcCtD
Telmisartan—Asthenia—Doxorubicin—liver cancer	8.13e-05	0.000826	CcSEcCtD
Telmisartan—Dizziness—Epirubicin—liver cancer	8.1e-05	0.000822	CcSEcCtD
Telmisartan—Pruritus—Doxorubicin—liver cancer	8.02e-05	0.000814	CcSEcCtD
Telmisartan—Vomiting—Epirubicin—liver cancer	7.79e-05	0.000791	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—liver cancer	7.76e-05	0.000787	CcSEcCtD
Telmisartan—Rash—Epirubicin—liver cancer	7.73e-05	0.000784	CcSEcCtD
Telmisartan—Dermatitis—Epirubicin—liver cancer	7.72e-05	0.000783	CcSEcCtD
Telmisartan—Headache—Epirubicin—liver cancer	7.68e-05	0.000779	CcSEcCtD
Telmisartan—Dizziness—Doxorubicin—liver cancer	7.5e-05	0.000761	CcSEcCtD
Telmisartan—Nausea—Epirubicin—liver cancer	7.28e-05	0.000739	CcSEcCtD
Telmisartan—Vomiting—Doxorubicin—liver cancer	7.21e-05	0.000732	CcSEcCtD
Telmisartan—Rash—Doxorubicin—liver cancer	7.15e-05	0.000726	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—liver cancer	7.14e-05	0.000725	CcSEcCtD
Telmisartan—Headache—Doxorubicin—liver cancer	7.1e-05	0.000721	CcSEcCtD
Telmisartan—Nausea—Doxorubicin—liver cancer	6.73e-05	0.000684	CcSEcCtD
Telmisartan—PPARG—Metabolism—HPGDS—liver cancer	2.91e-05	0.000392	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ALB—liver cancer	2.9e-05	0.00039	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTA4—liver cancer	2.86e-05	0.000384	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—IL6—liver cancer	2.85e-05	0.000383	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—EPT1—liver cancer	2.83e-05	0.000381	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	2.83e-05	0.000381	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CG—liver cancer	2.8e-05	0.000376	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—PPARA—liver cancer	2.79e-05	0.000375	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTA2—liver cancer	2.78e-05	0.000374	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP2E1—liver cancer	2.78e-05	0.000374	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—EPT1—liver cancer	2.76e-05	0.000372	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.69e-05	0.000362	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTA1—liver cancer	2.69e-05	0.000361	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TAT—liver cancer	2.68e-05	0.000361	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NAT2—liver cancer	2.66e-05	0.000357	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—F2—liver cancer	2.65e-05	0.000357	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	2.64e-05	0.000355	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.64e-05	0.000355	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—RAF1—liver cancer	2.64e-05	0.000354	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—RAF1—liver cancer	2.62e-05	0.000353	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TAT—liver cancer	2.62e-05	0.000352	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYCS—liver cancer	2.6e-05	0.00035	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.6e-05	0.00035	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PSMD10—liver cancer	2.59e-05	0.000349	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PSMA4—liver cancer	2.59e-05	0.000349	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GGT1—liver cancer	2.55e-05	0.000343	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GOT1—liver cancer	2.55e-05	0.000343	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALDOB—liver cancer	2.55e-05	0.000342	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CG—liver cancer	2.54e-05	0.000341	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	2.53e-05	0.00034	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GOT2—liver cancer	2.52e-05	0.000339	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CD—liver cancer	2.46e-05	0.000331	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CRABP1—liver cancer	2.43e-05	0.000327	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—PPARA—liver cancer	2.43e-05	0.000326	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP2E1—liver cancer	2.37e-05	0.000319	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.3e-05	0.000309	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTP1—liver cancer	2.29e-05	0.000308	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CTNNB1—liver cancer	2.28e-05	0.000307	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—HMOX1—liver cancer	2.26e-05	0.000304	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PRKCE—liver cancer	2.26e-05	0.000304	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—H2AFX—liver cancer	2.25e-05	0.000303	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—liver cancer	2.24e-05	0.000301	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CD—liver cancer	2.23e-05	0.0003	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	2.22e-05	0.000299	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYCS—liver cancer	2.22e-05	0.000299	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GGT1—liver cancer	2.18e-05	0.000293	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GOT1—liver cancer	2.18e-05	0.000293	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CB—liver cancer	2.14e-05	0.000288	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF2—liver cancer	2.14e-05	0.000288	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HPGDS—liver cancer	2.12e-05	0.000285	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTM1—liver cancer	2.11e-05	0.000283	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ALB—liver cancer	2.07e-05	0.000279	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	2.04e-05	0.000274	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—liver cancer	2.01e-05	0.00027	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PPARA—liver cancer	2.01e-05	0.00027	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP1A1—liver cancer	2e-05	0.000269	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CSF2—liver cancer	2e-05	0.000269	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	2e-05	0.000268	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—RAF1—liver cancer	1.99e-05	0.000268	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—STAT3—liver cancer	1.99e-05	0.000267	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.98e-05	0.000266	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—H2AFX—liver cancer	1.97e-05	0.000265	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—liver cancer	1.97e-05	0.000265	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—liver cancer	1.96e-05	0.000264	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTP1—liver cancer	1.96e-05	0.000263	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CB—liver cancer	1.95e-05	0.000262	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	1.94e-05	0.000261	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	1.94e-05	0.000261	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—HMOX1—liver cancer	1.93e-05	0.00026	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	1.92e-05	0.000259	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PSMD10—liver cancer	1.89e-05	0.000254	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PSMA4—liver cancer	1.89e-05	0.000254	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	1.88e-05	0.000253	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—RAF1—liver cancer	1.88e-05	0.000252	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	1.87e-05	0.000251	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—MTHFR—liver cancer	1.86e-05	0.000251	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MAPK14—liver cancer	1.85e-05	0.000249	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TGFB1—liver cancer	1.84e-05	0.000248	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GOT2—liver cancer	1.84e-05	0.000248	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	1.83e-05	0.000247	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPARA—liver cancer	1.83e-05	0.000246	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GLUL—liver cancer	1.82e-05	0.000245	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CPT1B—liver cancer	1.82e-05	0.000245	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ESR1—liver cancer	1.82e-05	0.000244	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—liver cancer	1.8e-05	0.000243	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTM1—liver cancer	1.8e-05	0.000242	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—liver cancer	1.79e-05	0.00024	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CPT1B—liver cancer	1.78e-05	0.00024	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GLUL—liver cancer	1.78e-05	0.00024	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TERT—liver cancer	1.78e-05	0.000239	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NR1H4—liver cancer	1.76e-05	0.000237	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP2E1—liver cancer	1.73e-05	0.000233	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA3—liver cancer	1.73e-05	0.000233	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—liver cancer	1.72e-05	0.000231	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NR1H4—liver cancer	1.72e-05	0.000231	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KRAS—liver cancer	1.71e-05	0.00023	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP1A1—liver cancer	1.71e-05	0.000229	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	1.69e-05	0.000228	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA3—liver cancer	1.69e-05	0.000227	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.64e-05	0.000221	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	1.63e-05	0.000219	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KDR—liver cancer	1.63e-05	0.000219	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	1.62e-05	0.000218	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYCS—liver cancer	1.62e-05	0.000218	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK14—liver cancer	1.62e-05	0.000218	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—MTHFR—liver cancer	1.59e-05	0.000214	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GGT1—liver cancer	1.59e-05	0.000214	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GOT1—liver cancer	1.59e-05	0.000214	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ESR1—liver cancer	1.59e-05	0.000213	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA4—liver cancer	1.58e-05	0.000213	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—F2—liver cancer	1.57e-05	0.000211	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CG—liver cancer	1.57e-05	0.00021	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PPARA—liver cancer	1.56e-05	0.00021	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	1.56e-05	0.000209	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	1.55e-05	0.000209	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.55e-05	0.000208	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA4—liver cancer	1.54e-05	0.000208	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA2—liver cancer	1.54e-05	0.000207	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPARG—liver cancer	1.51e-05	0.000203	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA2—liver cancer	1.5e-05	0.000202	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APC—liver cancer	1.5e-05	0.000202	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CG—liver cancer	1.5e-05	0.000202	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SERPINE1—liver cancer	1.49e-05	0.000201	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA1—liver cancer	1.49e-05	0.0002	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NAT2—liver cancer	1.47e-05	0.000198	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA1—liver cancer	1.45e-05	0.000195	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—liver cancer	1.45e-05	0.000195	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	1.45e-05	0.000195	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	1.44e-05	0.000194	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NAT2—liver cancer	1.44e-05	0.000193	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTP1—liver cancer	1.43e-05	0.000192	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.41e-05	0.00019	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALDOB—liver cancer	1.41e-05	0.00019	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BRAF—liver cancer	1.41e-05	0.00019	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HMOX1—liver cancer	1.41e-05	0.000189	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.4e-05	0.000188	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—liver cancer	1.39e-05	0.000187	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALDOB—liver cancer	1.38e-05	0.000185	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CD—liver cancer	1.38e-05	0.000185	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—liver cancer	1.36e-05	0.000183	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CRABP1—liver cancer	1.35e-05	0.000181	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CG—liver cancer	1.34e-05	0.00018	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.32e-05	0.000178	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CD—liver cancer	1.32e-05	0.000177	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CRABP1—liver cancer	1.31e-05	0.000177	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	1.31e-05	0.000177	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTM1—liver cancer	1.31e-05	0.000176	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—liver cancer	1.31e-05	0.000176	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SERPINE1—liver cancer	1.3e-05	0.000175	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—liver cancer	1.29e-05	0.000174	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—liver cancer	1.28e-05	0.000172	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.28e-05	0.000172	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1A1—liver cancer	1.24e-05	0.000167	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.21e-05	0.000163	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CB—liver cancer	1.2e-05	0.000161	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—liver cancer	1.19e-05	0.000159	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RAF1—liver cancer	1.18e-05	0.000158	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HPGDS—liver cancer	1.18e-05	0.000158	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CD—liver cancer	1.17e-05	0.000158	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.17e-05	0.000157	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—liver cancer	1.16e-05	0.000156	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—MTHFR—liver cancer	1.16e-05	0.000156	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MTOR—liver cancer	1.15e-05	0.000155	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CB—liver cancer	1.15e-05	0.000155	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HPGDS—liver cancer	1.15e-05	0.000154	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARA—liver cancer	1.14e-05	0.000153	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—liver cancer	1.1e-05	0.000148	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.08e-05	0.000145	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1B—liver cancer	1.08e-05	0.000145	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—liver cancer	1.07e-05	0.000143	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.06e-05	0.000143	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—liver cancer	1.06e-05	0.000142	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—liver cancer	1.06e-05	0.000142	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.05e-05	0.000141	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—liver cancer	1.05e-05	0.000141	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PSMA4—liver cancer	1.05e-05	0.000141	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PSMD10—liver cancer	1.05e-05	0.000141	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—liver cancer	1.03e-05	0.000138	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JUN—liver cancer	1.03e-05	0.000138	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CB—liver cancer	1.02e-05	0.000138	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PSMD10—liver cancer	1.02e-05	0.000138	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PSMA4—liver cancer	1.02e-05	0.000138	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GOT2—liver cancer	1.02e-05	0.000137	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CTNNB1—liver cancer	1.02e-05	0.000137	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—liver cancer	9.99e-06	0.000134	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1A—liver cancer	9.95e-06	0.000134	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GOT2—liver cancer	9.95e-06	0.000134	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	9.76e-06	0.000131	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CG—liver cancer	9.74e-06	0.000131	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK8—liver cancer	9.72e-06	0.000131	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—liver cancer	9.69e-06	0.00013	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2E1—liver cancer	9.59e-06	0.000129	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—liver cancer	9.45e-06	0.000127	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARG—liver cancer	9.4e-06	0.000126	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2E1—liver cancer	9.36e-06	0.000126	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.28e-06	0.000125	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—liver cancer	8.97e-06	0.000121	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYCS—liver cancer	8.97e-06	0.000121	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—liver cancer	8.88e-06	0.000119	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	8.82e-06	0.000119	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GGT1—liver cancer	8.8e-06	0.000118	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GOT1—liver cancer	8.8e-06	0.000118	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYCS—liver cancer	8.75e-06	0.000118	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GOT1—liver cancer	8.59e-06	0.000116	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GGT1—liver cancer	8.59e-06	0.000116	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CD—liver cancer	8.56e-06	0.000115	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—liver cancer	8.45e-06	0.000114	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—liver cancer	8.25e-06	0.000111	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—liver cancer	8.23e-06	0.000111	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTP1—liver cancer	7.91e-06	0.000106	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HMOX1—liver cancer	7.8e-06	0.000105	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTP1—liver cancer	7.72e-06	0.000104	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—liver cancer	7.63e-06	0.000103	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HMOX1—liver cancer	7.61e-06	0.000102	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CB—liver cancer	7.46e-06	0.0001	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—liver cancer	7.31e-06	9.83e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTM1—liver cancer	7.26e-06	9.77e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTM1—liver cancer	7.09e-06	9.53e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—liver cancer	7.01e-06	9.42e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1A1—liver cancer	6.89e-06	9.26e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—liver cancer	6.78e-06	9.12e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1A1—liver cancer	6.72e-06	9.04e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—liver cancer	6.55e-06	8.81e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—liver cancer	6.48e-06	8.72e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTHFR—liver cancer	6.42e-06	8.63e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARA—liver cancer	6.3e-06	8.47e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTHFR—liver cancer	6.27e-06	8.43e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—liver cancer	6.24e-06	8.39e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—liver cancer	6.2e-06	8.34e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARA—liver cancer	6.15e-06	8.27e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—liver cancer	5.97e-06	8.03e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—liver cancer	5.72e-06	7.7e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.66e-06	7.61e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CG—liver cancer	5.39e-06	7.25e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CG—liver cancer	5.26e-06	7.08e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARG—liver cancer	5.21e-06	7e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—liver cancer	5.1e-06	6.85e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARG—liver cancer	5.08e-06	6.83e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CD—liver cancer	4.74e-06	6.38e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—liver cancer	4.68e-06	6.29e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CD—liver cancer	4.63e-06	6.22e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—liver cancer	4.57e-06	6.14e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—liver cancer	4.55e-06	6.12e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CB—liver cancer	4.13e-06	5.56e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CB—liver cancer	4.03e-06	5.42e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—liver cancer	3.72e-06	5e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—liver cancer	2.52e-06	3.39e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—liver cancer	2.46e-06	3.31e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—liver cancer	2.06e-06	2.77e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—liver cancer	2.01e-06	2.7e-05	CbGpPWpGaD
